Concord Competitors

Stocks . Taiwan . 
Stock . Concord Medical Co
6518 Stock  TWD 26.40  0.15  0.56%   
Concord Medical competes with BioLASCO Taiwan, SS Healthcare, Radiant Innovation, General Biologicals, and Healthconn Corp; as well as few others. The company operates under Healthcare sector and is part of Medical Instruments & Supplies industry. Analyzing Concord Medical competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Concord Medical to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Concord Medical Correlation with its peers.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Concord Medical competition on your existing holdings.
  
Hype
Prediction
LowEstimatedHigh
25.0526.5528.05
Details
Intrinsic
Valuation
LowRealHigh
20.7422.2429.21
Details

Concord Medical Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Concord Medical and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Concord and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Concord Medical does not affect the price movement of the other competitor.

High positive correlations

6665
+ 0.86
3373
4192
+ 0.79
3373
3373
+ 0.76
6662
6665
+ 0.7
6662
6939
+ 0.68
3373
4192
+ 0.66
4198
  

High negative correlations

6939
- 0.58
6572
6939
- 0.38
4117
6917
- 0.37
6939
4198
- 0.34
6572
3373
- 0.31
6572
6665
- 0.29
4117

Risk-Adjusted Indicators

There is a big difference between Concord Stock performing well and Concord Medical Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Concord Medical's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
7575  1.22 (0.12) 0.00 (0.18) 0.00 
 0.00 
 2.44 
(3.75)
 11.05 
6572  3.00 (0.40) 0.00 (0.67) 0.00 
 0.00 
 6.36 
(6.13)
 19.47 
6662  0.94 (0.11) 0.00  1.53  0.00 
 0.00 
 2.14 
(1.84)
 5.46 
4198  1.78 (0.23) 0.00  0.43  0.00 
 0.00 
 3.31 
(4.55)
 13.56 
3373  0.68 (0.16) 0.00  4.06  0.00 
 0.00 
 0.87 
(1.64)
 4.31 
4117  2.76 (0.01) 0.00  0.08  0.00 
 0.00 
 4.37 
(7.14)
 38.50 
6939  2.10 (0.28) 0.00 (0.34) 0.00 
 0.00 
 3.70 
(4.29)
 32.88 
6665  1.38 (0.25) 0.00 (0.41) 0.00 
 0.00 
 3.18 
(3.71)
 10.47 
4192  1.49 (0.13) 0.00  3.84  0.00 
 0.00 
 4.11 
(4.49)
 11.26 
6917  1.93 (0.06) 0.00 (0.31) 0.00 
 0.00 
 4.78 
(4.03)
 9.99 
All Fundamental Data

Concord Medical Competitive Analysis

The better you understand Concord Medical competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Concord Medical's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Concord Medical's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
6518 7575 6572 6662 4198 3373 4117 6939 6665 4192
 0.56 
 26.40 
Concord
 1.10 
 26.90 
Amed
 2.82 
 7.57 
PlexBio
 0.99 
 30.55 
BioLASCO
 3.12 
 31.00 
4198
 0.57 
 17.35 
Radiant
 1.65 
 12.30 
General
 0.52 
 19.50 
TFBS
 0.49 
 20.40 
Healthconn
 0.41 
 24.35 
SynCore
Market Volatility
(90 Days Market Risk)
Very steady
Very steady
Slightly risky
Very steady
Very steady
Very steady
Slightly risky
Not too volatile
Very steady
Very steady
Market Performance
(90 Days Performance)
Soft
Weakest
Weakest
Weakest
Weakest
Weakest
Weakest
Weakest
Weakest
Weakest
Odds of Financial Distress
(Probability Of Bankruptcy)
Low
Unknown
Fair
Low
Moderate
Low
Moderate
Unknown
Low
Low
Current Valuation
(Equity Enterprise Value)
Over Valued
Over Valued
Over Valued
Fairly Valued
Over Valued
Fairly Valued
Over Valued
Under Valued
Fairly Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Strong Sell
Cautious Hold
Strong Sell
Strong Hold
Strong Sell
Strong Sell
Strong Sell
Cautious Hold
Cautious Hold
Strong Sell
Current Ratio
1.22
N/A
7.75
3.85
N/A
1.0
2.14
5.04
Net Asset
N/A
N/A
N/A
N/A
1.24 B
N/A
N/A
824.44 M
Profit Margin
3.05
N/A
19.91
N/A
0.071
-27.76
N/A
N/A
EBITDA
124.83 M
N/A
69.58 M
(177.78 M)
177.56 M
(41.94 M)
181.21 M
(404.13 M)
Operating Margin
4.22
N/A
23.75
N/A
0.0038
-25.08
N/A
-13.97
Current Valuation
749.07 M
N/A
595.07 M
N/A
987.21 M
420.71 M
N/A
2.86 B
Price To Book
0.93
N/A
1.68
N/A
1.15
3.58
N/A
9.34
Beta
0.47
N/A
0.44
0.48
-0.085
0.78
1.3
1.14
Number Of Employees
2
9
79
17
13
8
12
65
Shares Outstanding
25 M
N/A
25.61 M
N/A
43.29 M
39.89 M
N/A
115.08 M
Cash Flow From Operations
101.94 M
N/A
73.88 M
(147.41 M)
(135.16 M)
(15.9 M)
302.18 M
(229.86 M)
Annual Yield
N/A
N/A
N/A
N/A
0.0584
N/A
N/A
N/A
Total Debt
381.76 M
N/A
70.63 M
139.82 M
N/A
130.36 M
405.87 M
61.11 M
Return On Equity
4.63
N/A
11.09
N/A
0.0417
-58.61
N/A
-0.43
Z Score
0.6
N/A
6.6
0.6
N/A
1.2
3.6
28.2
Return On Asset
1.88
N/A
6.41
N/A
0.0012
-11.63
N/A
-0.16
Book Value Per Share
19.55
N/A
18.39
4.92
23.86
2.25
22.32
2.87
Total Asset
N/A
N/A
N/A
N/A
1.24 B
N/A
N/A
824.44 M
Debt To Equity
78.2
N/A
0.15
66.8
N/A
145.4
0.41
9.4
Last Dividend Paid
0.4
N/A
2.0
N/A
1.5
N/A
4.56
N/A
Market Capitalization
456.5 M
1.1 B
792.69 M
219.93 M
1.09 B
364.16 M
2.52 B
2.88 B
Price To Earning
20.56
N/A
15.25
N/A
N/A
N/A
21.7
N/A
Price To Sales
0.62
N/A
3.06
N/A
1.9
1.48
N/A
221.58
Net Income
22.33 M
N/A
51.55 M
(191.49 M)
112.47 M
(68.39 M)
118.03 M
(458.6 M)
Earnings Per Share
0.89
N/A
2.03
-4.5
1.0
-1.79
2.59
-3.73
Shares Owned By Insiders
N/A
N/A
47.69
N/A
28.78
N/A
N/A
66.92
Revenue
731 M
N/A
258.98 M
N/A
985.04 M
246.32 M
N/A
6.94 M
Cash And Equivalents
88.64 M
N/A
263.13 M
120.22 M
N/A
30.34 M
950.2 M
380.81 M
Cash Per Share
3.55
N/A
10.27
2.83
N/A
0.76
21.41
4.57
Gross Profit
56.78 M
N/A
130.29 M
N/A
307.55 M
117.05 M
N/A
2.97 M
Day Typical Price
26.57
26.92
7.52
30.38
31.32
17.42
12.3
19.42
20.33
24.4
Accumulation Distribution
259.36
408.25
17853.6
376.76
178.4
1295.63
2351.1
6433.6
176.76
40.48
Market Facilitation Index
1.0E-4
0.0
0.0
0.0
2.0E-4
0.0
0.0
0.0
0.0
0.0
Daily Balance Of Power
(0.21)
(0.86)
(0.37)
0.6
(1.05)
(0.33)
0.3333
0.087
0.5
0.6667
Period Momentum Indicator
(0.15)
(0.30)
(0.22)
0.3
(1.00)
(0.10)
0.2
0.1
0.1
0.1
Rate Of Daily Change
0.99
0.99
0.97
1.01
0.97
0.99
1.02
1.01
1.0
1.0
Day Median Price
26.65
26.93
7.5
30.3
31.48
17.45
12.3
19.38
20.3
24.43
Price Action Indicator
(0.33)
(0.18)
(0.04)
0.4
(0.97)
(0.15)
0.1
0.18
0.15
(0.03)
Coefficient Of Variation
1792.77
(2,329)
(1,198)
(1,143)
(949.39)
(595.57)
(11,384)
(1,733)
(950.29)
(1,797)
Mean Deviation
0.962
1.22
3.0
0.9378
1.78
0.6751
2.76
2.1
1.38
1.49
Jensen Alpha
0.0696
(0.12)
(0.40)
(0.11)
(0.23)
(0.16)
(0.01)
(0.28)
(0.25)
(0.13)
Total Risk Alpha
(0.06)
(0.25)
(0.74)
(0.22)
(0.49)
(0.24)
(0.58)
(0.58)
(0.39)
(0.33)
Sortino Ratio
0.0051
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Downside Variance
3.59
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Standard Deviation
1.5
1.86
4.24
1.21
2.48
0.8856
5.85
3.88
1.98
2.23
Kurtosis
2.46
2.26
2.22
(0.14)
1.24
0.8238
20.46
17.44
1.12
1.31
Potential Upside
2.55
2.44
6.36
2.14
3.31
0.8721
4.37
3.7
3.18
4.11
Treynor Ratio
1.1
(0.18)
(0.67)
1.53
0.4266
4.06
0.0819
(0.34)
(0.41)
3.84
Maximum Drawdown
8.22
11.05
19.47
5.46
13.56
4.31
38.5
32.88
10.47
11.26
Variance
2.26
3.47
18.01
1.47
6.13
0.7843
34.2
15.09
3.93
4.97
Market Risk Adjusted Performance
1.11
(0.17)
(0.66)
1.54
0.4366
4.07
0.0919
(0.33)
(0.40)
3.85
Risk Adjusted Performance
0.0459
(0.03)
(0.05)
(0.06)
(0.07)
(0.12)
0.0023
(0.03)
(0.07)
(0.03)
Skewness
0.3148
0.232
0.9101
0.1699
(0.67)
0.1844
3.94
2.5
(0.07)
0.0435
Semi Deviation
1.18
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Information Ratio
0.0065
(0.08)
(0.10)
(0.15)
(0.14)
(0.25)
(0.02)
(0.08)
(0.14)
(0.09)
Value At Risk
(2.59)
(3.75)
(6.13)
(1.84)
(4.55)
(1.64)
(7.14)
(4.29)
(3.71)
(4.49)
Expected Short fall
(1.57)
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Downside Deviation
1.9
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Semi Variance
1.38
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Concord Medical Competition Performance Charts

Five steps to successful analysis of Concord Medical Competition

Concord Medical's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Concord Medical in relation to its competition. Concord Medical's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Concord Medical in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Concord Medical's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Concord Medical, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Concord Medical position

In addition to having Concord Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Soft Drinks Thematic Idea Now

Soft Drinks
Soft Drinks Theme
Entities manufacturing and distributing non alcoholic beverages across different markets. The Soft Drinks theme has 7 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Soft Drinks Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Concord Stock Analysis

When running Concord Medical's price analysis, check to measure Concord Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Concord Medical is operating at the current time. Most of Concord Medical's value examination focuses on studying past and present price action to predict the probability of Concord Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Concord Medical's price. Additionally, you may evaluate how the addition of Concord Medical to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY